Literature DB >> 32726532

Treatment of Chronic Lymphocytic Leukemia.

Jan A Burger1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32726532     DOI： 10.1056/NEJMra1908213

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  44 in total

1.  Lymphocyte doubling time in chronic lymphocytic leukemia modern era: a real-life study in 848 unselected patients.

Authors:  Tycho Baumann; Riccardo Moia; Gianluca Gaidano; Julio Delgado; Adalgisa Condoluci; Neus Villamor; Anil Babu Payedimarri; Dolors Costa; Andrea Patriarca; Carlos Jiménez-Vicente; Davide Rossi; Emili Montserrat
Journal:  Leukemia       Date:  2021-02-04       Impact factor: 11.528

2.  Activation and expansion of T-follicular helper cells in chronic lymphocytic leukemia nurselike cell co-cultures.

Authors:  Alicia M Vaca; Nikolaos Ioannou; Mariela Sivina; Elisavet Vlachonikola; Karen Clise-Dwyer; Ekaterina Kim; Dan Li; Qing Ma; Alessandra Ferrajoli; Zeev Estrov; William G Wierda; Piers E M Patten; Alan G Ramsay; Jan A Burger
Journal:  Leukemia       Date:  2022-02-11       Impact factor: 11.528

Review 3.  Targeted Drug Delivery for Chronic Lymphocytic Leukemia.

Authors:  Makhloufi Zoulikha; Wei He
Journal:  Pharm Res       Date:  2022-03-07       Impact factor: 4.200

Review 4.  The cure of leukemia through the optimist's prism.

Authors:  Hagop M Kantarjian; Nitin Jain; Guillermo Garcia-Manero; Mary Alma Welch; Farhad Ravandi; William G Wierda; Elias J Jabbour
Journal:  Cancer       Date:  2021-10-06       Impact factor: 6.860

5.  Ibrutinib Plus Venetoclax for First-Line Treatment of Chronic Lymphocytic Leukemia: Primary Analysis Results From the Minimal Residual Disease Cohort of the Randomized Phase II CAPTIVATE Study.

Authors:  William G Wierda; John N Allan; Tanya Siddiqi; Thomas J Kipps; Stephen Opat; Alessandra Tedeschi; Xavier C Badoux; Bryone J Kuss; Sharon Jackson; Carol Moreno; Ryan Jacobs; John M Pagel; Ian Flinn; Yvonne Pak; Cathy Zhou; Edith Szafer-Glusman; Joi Ninomoto; James P Dean; Danelle F James; Paolo Ghia; Constantine S Tam
Journal:  J Clin Oncol       Date:  2021-10-07       Impact factor: 44.544

6.  SIRT3 overexpression and epigenetic silencing of catalase regulate ROS accumulation in CLL cells activating AXL signaling axis.

Authors:  Guru P Maiti; Sutapa Sinha; Hasan Mahmud; Justin Boysen; Mariana T Mendez; Sara K Vesely; Jennifer Holter-Chakrabarty; Neil E Kay; Asish K Ghosh
Journal:  Blood Cancer J       Date:  2021-05-17       Impact factor: 11.037

Review 7.  ER Stress and Unfolded Protein Response in Leukemia: Friend, Foe, or Both?

Authors:  Kelly Féral; Manon Jaud; Céline Philippe; Doriana Di Bella; Stéphane Pyronnet; Kevin Rouault-Pierre; Laurent Mazzolini; Christian Touriol
Journal:  Biomolecules       Date:  2021-01-30

Review 8.  BCL-2 Inhibition as Treatment for Chronic Lymphocytic Leukemia.

Authors:  Guilherme Fleury Perini; Carolina Cristina Pellegrino Feres; Larissa Lane Cardoso Teixeira; Nelson Hamerschlak
Journal:  Curr Treat Options Oncol       Date:  2021-06-10

Review 9.  The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment.

Authors:  Claudia Pérez-Carretero; Isabel González-Gascón-Y-Marín; Ana E Rodríguez-Vicente; Miguel Quijada-Álamo; José-Ángel Hernández-Rivas; María Hernández-Sánchez; Jesús María Hernández-Rivas
Journal:  Diagnostics (Basel)       Date:  2021-05-10

Review 10.  AID in Chronic Lymphocytic Leukemia: Induction and Action During Disease Progression.

Authors:  Pablo Oppezzo; Marcelo Navarrete; Nicholas Chiorazzi
Journal:  Front Oncol       Date:  2021-05-10       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.